Simulation Plus Revenue Jumps

The Lancaster pharmaceutical industry software maker Simulations Plus Inc. reported a 78 percent increase in consolidated revenues for the first quarter of fiscal year 2007, finishing at $1.45 million. Revenues from pharmaceutical software and services were up 314 percent to $824,000. Net income also went from $94,000 a year ago to $335,000. Earlier this month, the Food and Drug Administration agreed to license its GastroPlus simulation software.